Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

People with chronic Alopecia Areata often have lower vitamin D levels.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

People with alopecia areata have a higher risk of stroke.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Non-immune factors play a significant role in alopecia areata.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

People with alopecia areata have higher insulin resistance.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.